Key Quantitative Figures

  • Total Equity Shares Allotted: 2,28,116 equity shares of face value Re. 1/- each
  • Breakdown by ESOP Plan:
  • ESOP 2012: 1,76,568 shares
  • ESOP III 2020: 8,000 shares
  • ESOP IV 2021: 43,548 shares
  • Money Realized from Exercise: ₹6,71,651.00
  • Share Capital Increase: Paid-up capital increased from ₹74,92,94,369 to ₹74,95,22,485
  • Diluted EPS Post-allotment: Re. 1.02/-

Dates of Action

  • Approval Date: October 10, 2026 (Saturday)
  • Disclosure Date: October 10, 2026

Pricing Details

  • ESOP 2012 Exercise Prices:
  • 200 Options @ Re. 0.1/-
  • 1,60,268 Options @ Re. 1/-
  • 1,000 Options @ Rs. 16.28/-
  • 15,100 Options @ Rs. 29.85/-
  • ESOP III 2020 Exercise Price: 8,000 Options @ Re. 0.1/-
  • ESOP IV 2021 Exercise Price: 43,548 Options @ Re. 1/-

Capital Structure Impact

The equity shares allotted rank pari-passu with existing equity shares. The allotment results in a marginal increase of ₹2,28,116 in the company's paid-up share capital.

Additional Terms

The equity shares allotted are not subject to lock-in. The terms provide for adjustments in case of corporate actions and specify treatment for various employee exit scenarios.

Calculation Basis

The diluted earnings per share of Re. 1.02 is calculated based on the earnings reported by the Company for Q1FY27.